Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618
This examiner grants 42% of resolved cases
Leah H. Schlientz serves in Art Unit 1618 of Tech Center 1600. Her profile shows 601 resolved cases with an allowance rate of 41.9 percent. This 41.9 percent rate is higher than the 38.5 percent interview lift. The median days to allowance is 1547, which is a long duration for successful prosecution. This 1547 day timeline is a critical factor for applicants in Art Unit 1618.
The 38.5 percent interview lift indicates that direct communication is a vital strategy for improving the 41.9 percent baseline. With 601 cases resolved, the data reflects a consistent and challenging examination style. Practitioners should use the 1547 day median to set realistic expectations for patent issuance. The 601 case history in Tech Center 1600 suggests that while the allowance rate is low, the 38.5 percent lift offers a clear mechanism for overcoming rejections. This examiner requires a persistent and proactive approach to prosecution.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17742390 | COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME | Final Rejection | FUJIFILM Corporation |
| 17358544 | Methods for Cell Labeling and Medical Imaging | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18257974 | ISOCYCLOSERAM FORMULATION | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 18381930 | POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17588458 | MAGNETIC RESONANCE CONTRAST AGENTS AND METHODS THEREOF | Final Rejection | THE TEXAS A&M UNIVERSITY SYSTEM |
| 18545717 | TARGETING AND TREATMENT OF CANCEROUS CELLS USING RADIOLABELED GRP78-BINDING AGENTS | Non-Final OA | University of Kentucky Research Foundation |
| 18248045 | Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications | Final Rejection | OREGON HEALTH & SCIENCE UNIVERSITY |
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | Non-Final OA | UNIVERSITY OF COPENHAGEN |
| 18036723 | METHODS FOR TREATING CANCER USING COMBINATIONS OF EPIGENETIC THERAPIES AND RADIOCONJUGATE TARGETING AGENTS | Non-Final OA | ACTINIUM PHARMACEUTICALS, INC. |
| 18023526 | TUMOR CONTRAST COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN TUMOR DIAGNOSTIC IMAGING | Final Rejection | Zhejiang Haibo Biotech, Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy